Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
561.6 INR | -0.33% | -0.86% | -7.80% |
May. 20 | Lincoln Pharmaceuticals Limited Announces Director Appointments | CI |
May. 16 | Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 1,645
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 4,721 | 100.0 % | 5,103 | 100.0 % | +8.09% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rest of World
57.4
%
| 2,665 | 56.5 % | 2,931 | 57.4 % | +9.96% |
India
42.6
%
| 2,056 | 43.5 % | 2,172 | 42.6 % | +5.65% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 95-01-19 | |
Director of Finance/CFO | - | 19-03-27 | |
Chief Tech/Sci/R&D Officer | - | - | |
Compliance Officer | 30 | 22-11-09 | |
Chief Administrative Officer | - | - | |
Dhaval Gandhi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Director/Board Member | 43 | - | |
Director/Board Member | 42 | 14-11-13 | |
Director/Board Member | 66 | 95-01-19 | |
Bhavesh Patel
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 95-01-19 | |
Chairman | 80 | 95-08-15 | |
Director/Board Member | 66 | 95-01-19 | |
Director/Board Member | 42 | 14-11-13 | |
Director/Board Member | 43 | - | |
Director/Board Member | 52 | 18-03-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,029,728 | 8,642,988 ( 43.15 %) | 0 | 43.15 % |
Company contact information
Lincoln Pharmaceuticals Ltd.
Lincoln House Behind Satyam Complex
380060, Ahmedabad
+91 79 4107 8000
http://www.lincolnpharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-7.80% | 135M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- LINCOLN Stock
- Company Lincoln Pharmaceuticals Limited